Page last updated: 2024-09-03

imatinib mesylate and Pneumothorax, Primary Spontaneous

imatinib mesylate has been researched along with Pneumothorax, Primary Spontaneous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doi, T; Fujimi, A; Huang, Y; Ishizu, A; Iwasaki, S; Kanisawa, Y; Ohta, H; Okuda, T; Sato, Y; Tanaka, S1

Other Studies

1 other study(ies) available for imatinib mesylate and Pneumothorax, Primary Spontaneous

ArticleYear
[Spontaneous pneumothorax, an unusual manifestation of imatinib-resistant chronic eosinophilic leukemia: an autopsy study].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2009, Apr-10, Volume: 98, Issue:4

    Topics: Aged; Antineoplastic Agents; Autopsy; Benzamides; Drug Resistance, Neoplasm; Fatal Outcome; Gene Fusion; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Piperazines; Pneumothorax; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha

2009